Coloplast A/s
(OTC) CLPBF
Coloplast A/s Financials at a Glance
Market Cap
$15.10B
Revenue (TTM)
$27.88B
Net Income (TTM)
$3.99B
EPS (TTM)
$2.69
P/E Ratio
24.93
Dividend
$3.56
Beta (Volatility)
0.21 (Low)
Dividend
$3.56
Beta (Volatility)
0.21 (Low)
Price
$67.00
Volume
14
Open
$67.00
Price
$67.00
Volume
14
Open
$67.00
Previous Close
$67.00
Daily Range
$67.00 - $67.00
52-Week Range
$67.00 - $106.80
Dividend
$3.56
Beta (Volatility)
0.21 (Low)
Price
$67.00
Volume
14
Open
$67.00
Previous Close
$67.00
Daily Range
$67.00 - $67.00
52-Week Range
$67.00 - $106.80
CLPBF News
CLPBF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Coloplast A/s
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
16,907
CEO
Lars Søren Rasmussen, MBA
Website
www.coloplast.comHeadquarters
Humlebæk, 3050, DK
CLPBF Financials
Key Financial Metrics (TTM)
Gross Margin
65%
Operating Margin
27%
Net Income Margin
14%
Return on Equity
28%
Return on Capital
18%
Return on Assets
8%
Earnings Yield
4.01%
Dividend Yield
0.05%
Payout Ratio
1.30%
Stock Overview
Market Cap
$15.10B
Shares Outstanding
225.37M
Volume
14
Short Interest
0.00%
Avg. Volume
854.918
Financials (TTM)
Gross Profit
$18.10B
Operating Income
$7.57B
EBITDA
$8.32B
Operating Cash Flow
$6.63B
Capital Expenditure
$1.30B
Free Cash Flow
$5.33B
Cash & ST Invst.
$945.20M
Total Debt
$22.60B
Coloplast A/s Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$7.04B
+0.2%
Gross Profit
$4.74B
-0.3%
Gross Margin
67.23%
N/A
Market Cap
$15.10B
N/A
Market Cap/Employee
$901.95K
N/A
Employees
16,741
N/A
Net Income
$1.40B
+33.8%
EBITDA
$2.18B
-5.1%
Quarterly Fundamentals
Net Cash
$23.97B
-0.5%
Accounts Receivable
$4.84B
-2.5%
Inventory
$3.86B
+5.1%
Long Term Debt
$21.39B
+23.6%
Short Term Debt
$3.70B
-50.3%
Return on Assets
8.17%
N/A
Return on Invested Capital
18.39%
N/A
Free Cash Flow
$1.86B
+9.3%
Operating Cash Flow
$2.23B
+11.0%